Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane A Mitchell

Showing results (41-50 of 148) with videos related to

Pageof 15
Sort By:
Molecular Pharmacology|October 23, 2002
Cyclooxygenase-2 acts as an endogenous brake on endothelin-1 release by human pulmonary artery smooth muscle cells: implications for pulmonary hypertensionStephen J Wort, Mandy Woods, Timothy D Warner, et al.
Shock (Augusta, Ga.)|June 15, 2007
Identification and characterization of a dysfunctional cardiac myocyte phenotype: role of bacteria, Toll-like receptors, and endothelinTrupti A Patel, Elizabeth Belcher, Timothy D Warner, et al.
Nature Reviews. Drug Discovery|March 23, 2010
The safety and side effects of monoclonal antibodiesTrevor T Hansel, Harald Kropshofer, Thomas Singer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 22, 2009
PPARbeta/delta agonists modulate platelet function via a mechanism involving PPAR receptors and specific association/repression of PKCalpha--brief reportFerhana Y Ali, Matthew G Hall, Béatrice Desvergne, et al.
Molecular Medicine (Cambridge, Mass.)|January 31, 2008
Gram-positive and Gram-negative bacteria synergize with oxidants to release CXCL8 from innate immune cellsMark J Paul-Clark, Rosalinda Sorrentino, Lucy K Bailey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 21, 2003
Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior anti-inflammatory profile to corticosteroids: relevance for chronic obstructive pulmonary disease therapyHema J Patel, Maria G Belvisi, David Bishop-Bailey, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 19, 2004
Cyclooxygenases 1, 2, and 3 and the production of prostaglandin I2: investigating the activities of acetaminophen and cyclooxygenase-2-selective inhibitors in rat tissuesTimothy D Warner, Ivana Vojnovic, Francesco Giuliano, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 5, 2006
Stronger inhibition by nonsteroid anti-inflammatory drugs of cyclooxygenase-1 in endothelial cells than platelets offers an explanation for increased risk of thrombotic eventsJane A Mitchell, Ruth Lucas, Ivana Vojnovic, et al.
Respiratory Research|April 3, 2008
Differential regulation of CCL-11/eotaxin-1 and CXCL-8/IL-8 by gram-positive and gram-negative bacteria in human airway smooth muscle cellsRazao Issa, Rosalinda Sorrentino, Maria B Sukkar, et al.
The Journal of Endocrinology|May 31, 2007
Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and diseaseJane A Mitchell, Mark J Paul-Clark, Graham W Clarke, et al.
Pageof 15

Showing results (41-50 of 148) with videos related to

Sort By:
Pageof 15
Molecular Pharmacology|October 23, 2002
Cyclooxygenase-2 acts as an endogenous brake on endothelin-1 release by human pulmonary artery smooth muscle cells: implications for pulmonary hypertensionStephen J Wort, Mandy Woods, Timothy D Warner, et al.
Shock (Augusta, Ga.)|June 15, 2007
Identification and characterization of a dysfunctional cardiac myocyte phenotype: role of bacteria, Toll-like receptors, and endothelinTrupti A Patel, Elizabeth Belcher, Timothy D Warner, et al.
Nature Reviews. Drug Discovery|March 23, 2010
The safety and side effects of monoclonal antibodiesTrevor T Hansel, Harald Kropshofer, Thomas Singer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 22, 2009
PPARbeta/delta agonists modulate platelet function via a mechanism involving PPAR receptors and specific association/repression of PKCalpha--brief reportFerhana Y Ali, Matthew G Hall, Béatrice Desvergne, et al.
Molecular Medicine (Cambridge, Mass.)|January 31, 2008
Gram-positive and Gram-negative bacteria synergize with oxidants to release CXCL8 from innate immune cellsMark J Paul-Clark, Rosalinda Sorrentino, Lucy K Bailey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 21, 2003
Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior anti-inflammatory profile to corticosteroids: relevance for chronic obstructive pulmonary disease therapyHema J Patel, Maria G Belvisi, David Bishop-Bailey, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 19, 2004
Cyclooxygenases 1, 2, and 3 and the production of prostaglandin I2: investigating the activities of acetaminophen and cyclooxygenase-2-selective inhibitors in rat tissuesTimothy D Warner, Ivana Vojnovic, Francesco Giuliano, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 5, 2006
Stronger inhibition by nonsteroid anti-inflammatory drugs of cyclooxygenase-1 in endothelial cells than platelets offers an explanation for increased risk of thrombotic eventsJane A Mitchell, Ruth Lucas, Ivana Vojnovic, et al.
Respiratory Research|April 3, 2008
Differential regulation of CCL-11/eotaxin-1 and CXCL-8/IL-8 by gram-positive and gram-negative bacteria in human airway smooth muscle cellsRazao Issa, Rosalinda Sorrentino, Maria B Sukkar, et al.
The Journal of Endocrinology|May 31, 2007
Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and diseaseJane A Mitchell, Mark J Paul-Clark, Graham W Clarke, et al.
Pageof 15